Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00405743
Status:
COMPLETED
Last Update Posted:
2013-09-18
First Post:
2006-11-29
Brief Title:
A Phase III Study of CP-4055 in Patients With RefractoryRelapsed Hematologic Malignancies
Sponsor:
Clavis Pharma
Organization:
Clavis Pharma